Molecular laboratory processing has been advancing and in the Life Sciences field it is becoming more complex. This complexity is evident by Next Generation Sequencing moving beyond the research laboratory into Contract Research Organizations, Public Health, and Specialty Diagnostic testing. At the same time molecular testing is becoming more common in Biotechnology, Food and Beverage and Manufacturing. The distinguishing features of Molecular processes within the laboratory are the increased complexity of multistep protocols and the ability to affect many samples at one time due to the microscopic nature of the molecule. At the same time this increases the need to manage many more samples moving throughout the laboratory, and among many more systems that require integration with multiple instruments.
As CROs are becoming a more practical solution for biotech and pharmaceutical companies to perform their testing and are being more significantly scrutinized by oversight, quality and regulation industries. The FDA has been issuing warning letters to the sponsors and the agencies they are sponsoring due to poor documentation practices. As molecular testing is becoming more prominent in the clinical setting, the need to effectively manage molecular processes is becoming more necessary. Having a LIMS that can manage all molecular workflows along with other laboratory processes provides a means to demonstrate adherence to the regulations.
Molecular testing is becoming more affordable and now more mainstream. Even in the Public Health arena molecular assays are becoming the norm, and in the Clinical Diagnostic setting Next Generation Sequencing (NGS) is becoming more prominent for disease profiling. The proliferation of complex molecular testing such as that of NGS in clinical laboratories has led to new requirements and guidelines to be issued by CAP, CLIA, and ACMG. These cover the need for assay validation and the management of sample processing, the data obtained during testing and the release and dissemination of results.
CAP and CLIA inspectors are starting to familiarize themselves with these guidelines and the recertification process will become more tenuous. Laboratories that have implemented the new requirements and recommendations reduce the risk of having deficiencies found during inspections. Having a LIMS that can demonstrate effective management of these high complexity molecular processes, contributes to the growth and validity of the laboratory.
The food and beverage industry is continuing to expand scientifically and at the same time face more regulatory constraints. There has been an increase in the recalls issued and this may be due to the enforcement of the Food Safety Modernization Act (FSMA). Many recalls are based on the increased capability to perform more effective molecular testing of the products released to the market. As genomic tests are becoming more common for the identification of food borne pathogens, the ability to perform molecular testing, can expands past the inspection laboratories to become part of food and beverage manufacturers quality process prior to the release of product. Thus benefiting the industry by reducing product recalls. And as nutritional science continues to advance, there will be a need to demonstrate the genetic or molecular profile of food and beverage products, again expanding the laboratory’s need to manage molecular processes.
Besides manufactures who are creating molecular products for use within the industry as well as the life sciences research and clinical fields, molecular processes are becoming more commonplace in the Biopharmaceutical industry and not just during the research and development phase. One of the most complex molecular processes, Next Generation Sequencing (NGS) is turning into an opportune tool for the characterization of biological products, such as viral vaccines, cell lines, final drug products. At the same time instruments that create oligonucleotides are being utilized to create molecular tags used in other molecular assays and more recently to molecularly label manufactured products, for the ultimate identification of product origin. Having a LIMS that can track the manufacturing process from start to finish and include the molecular functionalities provides traceability of the product and source materials and quality metrics.
The STARLIMS Molecular functionality incorporates seamlessly into your laboratory workflow to allow for a single system to manage the complexity of molecular sample and specimen processing.
Sign up to receive the latest informatics resources, including webinars, case studies, and more.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimised for your screen size.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.